Effects of anticholinergic drugs on cognitive function in older Austalians: Results from the AIBL study
| Main Authors: | Sittironnarit, G., Ames, D., Bush, A., Faux, N., Flicker, L., Foster, Jonathan, Hilmer, S., Lautenschlager, N., Maruff, P., Masters, C., Martins, R., Rowe, C., Szoeke, C., Ellis, K. |
|---|---|
| Format: | Journal Article |
| Published: |
S. Karger AG
2011
|
| Online Access: | http://hdl.handle.net/20.500.11937/16993 |
Similar Items
Longitudinal cognitive decline in the AIBL cohort: The role of APOE e4 status
by: Albrecht, Matthew, et al.
Published: (2015)
by: Albrecht, Matthew, et al.
Published: (2015)
Longitudinal cognitive decline in the AIBL cohort: the role of APOE ε4 status
by: Foster, J., et al.
Published: (2014)
by: Foster, J., et al.
Published: (2014)
Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
by: Pike, K., et al.
Published: (2011)
by: Pike, K., et al.
Published: (2011)
Impact of Mild Head Injury on Neuropsychological Performance in Healthy Older Adults: Longitudinal Assessment in the AIBL Cohort
by: Albrecht, Matthew, et al.
Published: (2016)
by: Albrecht, Matthew, et al.
Published: (2016)
Plasma Amyloid-beta as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging
by: Lui, J., et al.
Published: (2010)
by: Lui, J., et al.
Published: (2010)
Anticholinergic burden in older women: not seeing the wood for the trees?
by: Parkinson, L., et al.
Published: (2015)
by: Parkinson, L., et al.
Published: (2015)
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer’s disease
by: Ellis, K., et al.
Published: (2009)
by: Ellis, K., et al.
Published: (2009)
Taste of traditional Bidayuh life for Austalian Expedition crew
by: The Star
Published: (2013)
by: The Star
Published: (2013)
The association between anticholinergic load and cognitive performance, elevated blood pressure and the presence of peripheral anticholinergic side effects.
by: Hughes, Jeffery, et al.
Published: (2009)
by: Hughes, Jeffery, et al.
Published: (2009)
Associations between gonadotropins, testosterone and [beta] amyloid in men at risk of Alzheimer’s disease
by: Verdile, Giuseppe, et al.
Published: (2014)
by: Verdile, Giuseppe, et al.
Published: (2014)
Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study
by: Foster, Jonathan, et al.
Published: (2013)
by: Foster, Jonathan, et al.
Published: (2013)
Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies
by: Martins, R., et al.
Published: (2018)
by: Martins, R., et al.
Published: (2018)
Anticholinergic toxidromeofdatura toxicity: neostigmine
reverses its toxicity
by: Mohamad, Nasir
Published: (2011)
by: Mohamad, Nasir
Published: (2011)
Trajectories of depressive and anxiety symptoms in older adults: a 6-year prospective cohort study
by: Holmes, S., et al.
Published: (2018)
by: Holmes, S., et al.
Published: (2018)
Comparison of risk of neurovascular and cardiovascular side effects between tiotropium and other anticholinergic agents
by: Alzayer, R., et al.
Published: (2010)
by: Alzayer, R., et al.
Published: (2010)
ß-Amyloid, APOE and BDNF Genotype, and Depressive and Anxiety Symptoms in Cognitively Normal Older Women and Men
by: Holmes, S., et al.
Published: (2016)
by: Holmes, S., et al.
Published: (2016)
Anticholinergic delirium superimposed on severe cognitive deficit secondary to benzhexol and flupenthixol decanoate: A dilemma in management
by: Misron, Siti Nor Fadhlina, et al.
Published: (2018)
by: Misron, Siti Nor Fadhlina, et al.
Published: (2018)
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
by: Burnham, S., et al.
Published: (2016)
by: Burnham, S., et al.
Published: (2016)
Anticholinergic drug burden tools/scales and adverse outcomes in different clinical settings: a systematic review of reviews
by: Welsh, Tomas J., et al.
Published: (2018)
by: Welsh, Tomas J., et al.
Published: (2018)
KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4-positive cognitively normal adults with high Aß-amyloid burden
by: Porter, T., et al.
Published: (2018)
by: Porter, T., et al.
Published: (2018)
Dietary patterns are associated with cognition among older people with mild cognitive impairment
by: Torres, S., et al.
Published: (2012)
by: Torres, S., et al.
Published: (2012)
Awareness of cognitive deficits in older adults with Cognitive-impairment-no-dementia (CIND): Comparison with informant report
by: Greenop, K., et al.
Published: (2011)
by: Greenop, K., et al.
Published: (2011)
Klotho allele status is not associated with Aß and APOE e4–related cognitive decline in preclinical Alzheimer's disease
by: Porter, T., et al.
Published: (2019)
by: Porter, T., et al.
Published: (2019)
Increased Carbohydrate Intake is Associated with Poorer Performance in Verbal Memory and Attention in an APOE Genotype-Dependent Manner
by: Gardener, S., et al.
Published: (2017)
by: Gardener, S., et al.
Published: (2017)
BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF
by: Lim, Y., et al.
Published: (2017)
by: Lim, Y., et al.
Published: (2017)
A randomized controlled trial of physical activity with individual goal-setting and volunteer mentors to overcome sedentary lifestyle in older adults at risk of cognitive decline: The INDIGO trial protocol
by: Cox, K., et al.
Published: (2017)
by: Cox, K., et al.
Published: (2017)
Amyloid ß–associated cognitive decline in the absence of clinical disease progression and systemic illness
by: Harrington, K., et al.
Published: (2017)
by: Harrington, K., et al.
Published: (2017)
Erratum: Clearance mechanisms of Alzheimer's amyloid-? peptide: Implications for therapeutic design and diagnostic tests (Molecular Psychiatry (2009) 14 (469-486) DOI: 10.1038/mp.2008.96)
by: Bates, K., et al.
Published: (2009)
by: Bates, K., et al.
Published: (2009)
Clearance mechanisms of Alzheimer’s amyloid-b peptide: implications for therapeutic design and diagnostic tests
by: Bates, K., et al.
Published: (2009)
by: Bates, K., et al.
Published: (2009)
Effects of physical activity on cognitive function in older adults at risk for Alzheimer disease: A randomized trial
by: Lautenschlager, N., et al.
Published: (2008)
by: Lautenschlager, N., et al.
Published: (2008)
A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease
by: Porter, T., et al.
Published: (2018)
by: Porter, T., et al.
Published: (2018)
Factors associated with depression in older carers
by: Loi, S., et al.
Published: (2015)
by: Loi, S., et al.
Published: (2015)
Two-year course of cognitive function and mood in adults with congestive heart failure and coronary artery disease: The Heart-Mind Study
by: Almeida, O., et al.
Published: (2012)
by: Almeida, O., et al.
Published: (2012)
Attitudes to aging in older carers - Do they have a role in their well-being?
by: Loi, S., et al.
Published: (2015)
by: Loi, S., et al.
Published: (2015)
Factors Associated with Self and Informant Ratings of the Quality of Life of People with Dementia Living in Care Facilities: A Cross Sectional Study
by: Beer, C., et al.
Published: (2010)
by: Beer, C., et al.
Published: (2010)
Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
by: Porter, T., et al.
Published: (2018)
by: Porter, T., et al.
Published: (2018)
Reduced awareness of executive dysfunction in Alzheimer's disease is associated with increased carer burden
by: Booney, K., et al.
Published: (2007)
by: Booney, K., et al.
Published: (2007)
The predictors of short- and long-term physical activity levels of older adults from FABS (Fitness for the Ageing Brain Study)
by: Cox, K., et al.
Published: (2012)
by: Cox, K., et al.
Published: (2012)
Improving pressure ulcer management in Australian nursing homes: results of the PRIME Trial organisational study
by: Ellis, I., et al.
Published: (2006)
by: Ellis, I., et al.
Published: (2006)
Grey matter changes associated with deficit awareness in mild cognitive impairment: a voxel-based morphometry study
by: Ford, A., et al.
Published: (2014)
by: Ford, A., et al.
Published: (2014)
Similar Items
-
Longitudinal cognitive decline in the AIBL cohort: The role of APOE e4 status
by: Albrecht, Matthew, et al.
Published: (2015) -
Longitudinal cognitive decline in the AIBL cohort: the role of APOE ε4 status
by: Foster, J., et al.
Published: (2014) -
Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
by: Pike, K., et al.
Published: (2011) -
Impact of Mild Head Injury on Neuropsychological Performance in Healthy Older Adults: Longitudinal Assessment in the AIBL Cohort
by: Albrecht, Matthew, et al.
Published: (2016) -
Plasma Amyloid-beta as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging
by: Lui, J., et al.
Published: (2010)